Logo image of ASTK.OL

ASETEK A/S (ASTK.OL) Stock Fundamental Analysis

OSL:ASTK - Euronext Oslo - DK0060477263 - Common Stock - Currency: NOK

6.34  +0.06 (+0.96%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ASTK. ASTK was compared to 28 industry peers in the Technology Hardware, Storage & Peripherals industry. ASTK has only an average score on both its financial health and profitability. ASTK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ASTK was profitable.
ASTK had a positive operating cash flow in the past year.
In multiple years ASTK reported negative net income over the last 5 years.
ASTK had a positive operating cash flow in 4 of the past 5 years.
ASTK.OL Yearly Net Income VS EBIT VS OCF VS FCFASTK.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 10M -10M -20M -30M

1.2 Ratios

ASTK has a Return On Assets of 5.01%. This is in the better half of the industry: ASTK outperforms 78.26% of its industry peers.
ASTK has a Return On Equity of 7.60%. This is in the better half of the industry: ASTK outperforms 78.26% of its industry peers.
The Return On Invested Capital of ASTK (6.99%) is better than 78.26% of its industry peers.
Industry RankSector Rank
ROA 5.01%
ROE 7.6%
ROIC 6.99%
ROA(3y)3.05%
ROA(5y)3.03%
ROE(3y)4%
ROE(5y)3.96%
ROIC(3y)N/A
ROIC(5y)N/A
ASTK.OL Yearly ROA, ROE, ROICASTK.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 7.21%, ASTK is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
The Operating Margin of ASTK (10.56%) is better than 73.91% of its industry peers.
Looking at the Gross Margin, with a value of 44.62%, ASTK is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
In the last couple of years the Gross Margin of ASTK has grown nicely.
Industry RankSector Rank
OM 10.56%
PM (TTM) 7.21%
GM 44.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.07%
GM growth 5Y2.61%
ASTK.OL Yearly Profit, Operating, Gross MarginsASTK.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20 30 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ASTK is creating some value.
ASTK has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ASTK is higher compared to a year ago.
ASTK.OL Yearly Shares OutstandingASTK.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M
ASTK.OL Yearly Total Debt VS Total AssetsASTK.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

ASTK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.03
WACC6.79%
ASTK.OL Yearly LT Debt VS Equity VS FCFASTK.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 1.70 indicates that ASTK should not have too much problems paying its short term obligations.
The Current ratio of ASTK (1.70) is comparable to the rest of the industry.
ASTK has a Quick Ratio of 1.70. This is a normal value and indicates that ASTK is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ASTK (1.70) is better than 78.26% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.7
ASTK.OL Yearly Current Assets VS Current LiabilitesASTK.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 137.48% over the past year.
ASTK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.76%.
ASTK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.74% yearly.
EPS 1Y (TTM)137.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%163.62%
Revenue 1Y (TTM)16.76%
Revenue growth 3Y-2.31%
Revenue growth 5Y-2.74%
Sales Q2Q%96.23%

3.2 Future

Based on estimates for the next years, ASTK will show a very strong growth in Earnings Per Share. The EPS will grow by 47.58% on average per year.
The Revenue is expected to grow by 21.29% on average over the next years. This is a very strong growth
EPS Next Y194.44%
EPS Next 2Y71.59%
EPS Next 3Y47.58%
EPS Next 5YN/A
Revenue Next Year47.06%
Revenue Next 2Y26.8%
Revenue Next 3Y21.29%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ASTK.OL Yearly Revenue VS EstimatesASTK.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
ASTK.OL Yearly EPS VS EstimatesASTK.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 0 0.2 -0.2 0.4 -0.4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.74, which indicates a correct valuation of ASTK.
Based on the Price/Earnings ratio, ASTK is valued cheaply inside the industry as 82.61% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.45, ASTK is valued a bit cheaper.
With a Price/Forward Earnings ratio of 8.29, the valuation of ASTK can be described as very reasonable.
Based on the Price/Forward Earnings ratio, ASTK is valued a bit cheaper than the industry average as 73.91% of the companies are valued more expensively.
ASTK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.89.
Industry RankSector Rank
PE 14.74
Fwd PE 8.29
ASTK.OL Price Earnings VS Forward Price EarningsASTK.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ASTK is valued a bit cheaper than the industry average as 78.26% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.01
ASTK.OL Per share dataASTK.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

ASTK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ASTK's earnings are expected to grow with 47.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y71.59%
EPS Next 3Y47.58%

0

5. Dividend

5.1 Amount

No dividends for ASTK!.
Industry RankSector Rank
Dividend Yield N/A

ASETEK A/S

OSL:ASTK (3/26/2024, 7:00:00 PM)

6.34

+0.06 (+0.96%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap615.35M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.74
Fwd PE 8.29
P/S 0.83
P/FCF N/A
P/OCF 6.88
P/B 0.88
P/tB 0.88
EV/EBITDA 5.01
EPS(TTM)0.43
EY6.78%
EPS(NY)0.76
Fwd EY12.06%
FCF(TTM)-1.91
FCFYN/A
OCF(TTM)0.92
OCFY14.53%
SpS7.64
BVpS7.24
TBVpS7.24
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.01%
ROE 7.6%
ROCE 9.07%
ROIC 6.99%
ROICexc 6.99%
ROICexgc 6.99%
OM 10.56%
PM (TTM) 7.21%
GM 44.62%
FCFM N/A
ROA(3y)3.05%
ROA(5y)3.03%
ROE(3y)4%
ROE(5y)3.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.07%
GM growth 5Y2.61%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 72.72%
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.7
Altman-Z N/A
F-Score7
WACC6.79%
ROIC/WACC1.03
Cap/Depr(3y)362.95%
Cap/Depr(5y)248.22%
Cap/Sales(3y)24.44%
Cap/Sales(5y)16.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)137.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%163.62%
EPS Next Y194.44%
EPS Next 2Y71.59%
EPS Next 3Y47.58%
EPS Next 5YN/A
Revenue 1Y (TTM)16.76%
Revenue growth 3Y-2.31%
Revenue growth 5Y-2.74%
Sales Q2Q%96.23%
Revenue Next Year47.06%
Revenue Next 2Y26.8%
Revenue Next 3Y21.29%
Revenue Next 5YN/A
EBIT growth 1Y281.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year420%
EBIT Next 3Y81.71%
EBIT Next 5YN/A
FCF growth 1Y-432.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.31%
OCF growth 3YN/A
OCF growth 5YN/A